Cloning, expression and purification of sPLA2 protein

PG Payal Gupta
PD Prasanta K. Dash
request Request a Protocol
ask Ask a question
Favorite

Total RNA isolated from flax leaves was used for cDNA synthesis using SuperScript™ III First-Strand Synthesis supermix following the manufacturer’s instructions (Life technologies Corporation). Sequence of flax sPLA2 isoform LusPLA 2 I (Genbank accession: KU361324) and LusPLA 2 II (Genbank accession: KU361324) were amplified using primer pairs listed in Supplementary Table S7. The amplified gene products were cloned in Gateway entry vector pENTR/SD/D/TOPO (Life technologies Corporation) as per manufacturer’s instructions and authenticity was confirmed by sequencing. For protein expression, the LusPLA 2 I and LusPLA 2 II genes were mobilized from entry vector into the destination vector, pET301/CT-DEST (Invitrogen Corporation) to generate the expression clones pET301/CT-DEST harbouring LusPLA 2 I-6xHis and pET301/CT-DEST harbouring LusPLA 2 II-6xHis as per manufacturer’s instructions.

The E.coli (CodonPlus (DE3)-RIPL cells (Agilent Technologies) cells harbouring the LusPLA 2 I- 6xHis and LusPLA 2 II-6xHis recombinant plasmid were grown at 37°C in LB medium containing 100 µg/ml carbenicillin until OD600 = 0.6 and induced with 0.4 mM IPTG (isopropyl-β-D-thiogalactopyranoside) for 4 h. The cells were harvested by centrifugation at 10,000 rpm, 4°C for 10 min and lysed by re-suspending in native lysis buffer containing lysozyme and sonicated at 24–25% amplitude 30 sec ON/OFF cycle on ice for 12–15 minutes ON condition. The recombinant proteins were purified by using Ni-NTA affinity chromatography by using QIAexpress® Ni-NTA Fast Start kit by following manufacturer’s instructions. The purity and yield of recombinant protein were analysed by SDS-PAGE and protein content was determined by Bradford’s method62.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A